178 related articles for article (PubMed ID: 37249796)
21. Poorly differentiated neuroendocrine carcinomas of the pancreas: a clinicopathologic analysis of 44 cases.
Basturk O; Tang L; Hruban RH; Adsay V; Yang Z; Krasinskas AM; Vakiani E; La Rosa S; Jang KT; Frankel WL; Liu X; Zhang L; Giordano TJ; Bellizzi AM; Chen JH; Shi C; Allen P; Reidy DL; Wolfgang CL; Saka B; Rezaee N; Deshpande V; Klimstra DS
Am J Surg Pathol; 2014 Apr; 38(4):437-47. PubMed ID: 24503751
[TBL] [Abstract][Full Text] [Related]
22. Pancreatic-type Acinar Cell Carcinoma of the Stomach Included in Multiple Primary Carcinomas.
Yonenaga Y; Kurosawa M; Mise M; Yamagishi M; Higashide S
Anticancer Res; 2016 Jun; 36(6):2855-64. PubMed ID: 27272797
[TBL] [Abstract][Full Text] [Related]
23. [Analysis of clinicopathological characteristics, therapeutic strategy and prognosis of 501 patients with gastric neuroendocrine neoplasms attending a single center].
Zhang BL; Lu YX; Liang WQ; Gao YH; Xi HQ; Wang XX; Zhang KC; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 May; 26(5):459-466. PubMed ID: 37217354
[No Abstract] [Full Text] [Related]
24. A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.
Tang LH; Basturk O; Sue JJ; Klimstra DS
Am J Surg Pathol; 2016 Sep; 40(9):1192-202. PubMed ID: 27259015
[TBL] [Abstract][Full Text] [Related]
25. [Clinicopathologic characterisitics of pancreatic acinar cell carcinomas].
Ding XH; Wang ZB; Qiu XM
Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):274-278. PubMed ID: 29690667
[No Abstract] [Full Text] [Related]
26. Non-Ductal Tumors of the Pancreas.
Dhillon J
Monogr Clin Cytol; 2020; 26():92-108. PubMed ID: 32987393
[TBL] [Abstract][Full Text] [Related]
27. The prevalence of pancreatic acinar differentiation in gastric adenocarcinoma: report of a case and immunohistochemical study of 111 additional cases.
Lee H; Tang LH; Veras EF; Klimstra DS
Am J Surg Pathol; 2012 Mar; 36(3):402-8. PubMed ID: 22082608
[TBL] [Abstract][Full Text] [Related]
28. Histologic characterization and improved prognostic evaluation of 209 gastric neuroendocrine neoplasms.
La Rosa S; Inzani F; Vanoli A; Klersy C; Dainese L; Rindi G; Capella C; Bordi C; Solcia E
Hum Pathol; 2011 Oct; 42(10):1373-84. PubMed ID: 21531442
[TBL] [Abstract][Full Text] [Related]
29. Spleen metastases secondary to gastric neuroendocrine carcinoma: case report.
Nasr S; Khsiba A; Mahmoudi M; Mohamed AB; Bouasida M; Hamzaoui L
Pan Afr Med J; 2022; 42():131. PubMed ID: 36060838
[TBL] [Abstract][Full Text] [Related]
30. Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms.
Rindi G; Mete O; Uccella S; Basturk O; La Rosa S; Brosens LAA; Ezzat S; de Herder WW; Klimstra DS; Papotti M; Asa SL
Endocr Pathol; 2022 Mar; 33(1):115-154. PubMed ID: 35294740
[TBL] [Abstract][Full Text] [Related]
31. [A case of mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN) diagnosed by re-biopsy of the enlarged primary tumor during chemotherapy for gastric adenocarcinoma].
Fuchino M; Nakaya A; Ando T; Hasumoto Y; Ozawa K; Ito H; Yabushita K; Miwa S; Hayashi S
Nihon Shokakibyo Gakkai Zasshi; 2024; 121(1):55-62. PubMed ID: 38220181
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological characteristics of gastric neuroendocrine neoplasms: A comprehensive analysis.
Zi M; Ma Y; Chen J; Pang C; Li X; Yuan L; Liu Z; Yu P
Cancer Med; 2024 Feb; 13(4):e7011. PubMed ID: 38457192
[TBL] [Abstract][Full Text] [Related]
33. [Amphicrine carcinoma of the pancreas. Report of two cases].
Sylla A; Hervieu V; Lombard-Bohas C; Tanière P; Elbaz N; Scoazec JY
Ann Pathol; 2003 Oct; 23(5):424-9. PubMed ID: 14752385
[TBL] [Abstract][Full Text] [Related]
34. Long-term surgical outcomes of gastric neuroendocrine carcinoma and mixed neuroendocrine-non-neuroendocrine neoplasms.
Iwasaki K; Barroga E; Enomoto M; Tsurui K; Shimoda Y; Matsumoto M; Miyoshi K; Ota Y; Matsubayashi J; Nagakawa Y
World J Surg Oncol; 2022 May; 20(1):165. PubMed ID: 35610656
[TBL] [Abstract][Full Text] [Related]
35. Carboxypeptidase A1 and regenerating islet-derived 1α as new markers for pancreatic acinar cell carcinoma.
Said S; Kurtin PJ; Nasr SH; Graham RP; Dasari S; Vrana JA; Yasir S; Torbenson MS; Zhang L; Mounajjed T; Eric Chen ZM; Lee HE; Wu TT
Hum Pathol; 2020 Sep; 103():120-126. PubMed ID: 32702400
[TBL] [Abstract][Full Text] [Related]
36. Mixed adenoneuroendocrine carcinoma of the gallbladder, amphicrine type: Case report and review of literature.
Zhang D; Li P; Szankasi P; Liao X
Pathol Res Pract; 2020 Jul; 216(7):152997. PubMed ID: 32534704
[TBL] [Abstract][Full Text] [Related]
37. The cytologic and immunohistochemical findings of pancreatic mixed acinar-endocrine carcinoma.
Whitehair R; Stelow EB
Diagn Cytopathol; 2021 Feb; 49(2):287-294. PubMed ID: 33128511
[TBL] [Abstract][Full Text] [Related]
38. Pancreatic-type Mixed Acinar-neuroendocrine Carcinoma of the Stomach: A Case Report and Literature Review.
Saller J; Hough B; Coppola D
Cancer Diagn Progn; 2021; 1(4):285-288. PubMed ID: 35403148
[TBL] [Abstract][Full Text] [Related]
39. Mixed Adenoneuroendocrine Carcinoma, Amphicrine Type, of the Small Bowel.
Ludmir EB; McCall SJ; Cardona DM; Perkinson KR; Guy CD; Zhang X
Am J Clin Pathol; 2016 May; 145(5):703-9. PubMed ID: 27124941
[TBL] [Abstract][Full Text] [Related]
40. A Subset of Large Cell Neuroendocrine Carcinomas in the Gastroenteropancreatic Tract May Evolve from Pre-existing Well-Differentiated Neuroendocrine Tumors.
Pelosi G; Bianchi F; Dama E; Metovic J; Barella M; Sonzogni A; Albini A; Papotti M; Gong Y; Vijayvergia N
Endocr Pathol; 2021 Sep; 32(3):396-407. PubMed ID: 33433886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
